Inogen launches Aurora CPAP masks, enters sleep apnea market

Inogen Inc., a medical technology company focused on respiratory products for home use, has launched a new line of continuous positive airway pressure masks, marking its entry into the sleep apnea market.

The company said the Aurora CPAP masks expand its respiratory care portfolio beyond oxygen therapy and into treatment for obstructive sleep apnea, a condition affecting millions of patients worldwide.

“The launch of Aurora CPAP masks represents a pivotal step in Inogen’s evolution towards expanding into a broad home care respiratory solutions company and our entry into the sleep apnea market,” said Kevin Smith, president and chief executive officer.

The Aurora masks are designed for comfort, reliability and ease of use, positioning the company in the growing sleep-therapy market. Inogen said it plans to use its existing distribution channels and provider partnerships to bring the masks to patients and strengthen relationships with home care providers.

“With Aurora Masks, we are bringing the same patient-centric innovation that defines our respiratory solutions to a new category, delivering comfort, performance, and reliability,” Smith said. “We see Aurora Masks as a growth catalyst that reinforces our commitment to leading in patient outcomes in home respiratory care.”

The launch is supported by a patient-use study in which the majority of participants reported being highly satisfied with the Aurora masks, the company said.

The Aurora portfolio includes three options — a full-face mask, a nasal cushion mask and nasal pillows — designed to accommodate a range of facial structures and therapy needs. Features include a triple-material headgear design with ultrasonic edge sealing, a medical-grade silicone cushion intended to reduce facial pressure, a quiet honeycomb vent to limit noise, and components designed for easy assembly and cleaning. The masks are universally compatible with most CPAP devices and have received FDA 510(k) clearance.

Sleep therapy technology continues to evolve

The launch comes amid rapid innovation in the sleep apnea and home sleep-therapy sector, driven by rising diagnosis rates, greater awareness of untreated sleep disorders, and growing demand for patient-friendly home care solutions.

Recent advances have focused heavily on improving patient adherence, long a challenge in CPAP therapy. Designers are increasingly prioritizing comfort, lighter materials, quieter airflow systems and masks that accommodate different sleeping positions. These refinements aim to address common complaints such as skin irritation, air leaks and noise, which are leading reasons patients abandon therapy.

Digital integration is also reshaping sleep therapy. Many newer CPAP systems now include wireless connectivity that allows clinicians to remotely monitor usage patterns, mask fit and therapy effectiveness. This data-driven approach enables earlier interventions when patients struggle with compliance and supports more personalized treatment plans.

Another area of progress is the use of artificial intelligence and advanced algorithms to automatically adjust pressure settings throughout the night. These systems respond in real time to changes in breathing patterns, potentially improving comfort while maintaining therapeutic effectiveness.

Regulatory agencies have also placed greater emphasis on safety, performance and post-market surveillance, particularly as sleep therapy increasingly shifts into the home. As a result, manufacturers are investing more in clinical validation, patient-use studies and real-world evidence to demonstrate both effectiveness and usability.

Together, these trends reflect a broader shift toward patient-centered respiratory care, where comfort, convenience and connectivity are viewed as essential components of successful long-term therapy rather than optional enhancements.